Precision Chroma
Christchurch, New Zealand
◆ Total Raised
$7.3M
◆ Stage
seed
◆ Location
Christchurch, New Zealand
◆ Founded
2022
◆ Team size
1-10
◆ Links
◆ About Precision Chroma
Christchurch-based biotechnology startup developing a new method of chromatography for faster and simpler purification of biological products.
◆ What sets it apart
Its patented Printed Monolith Adsorption technology uses 3D-printed hydrogel columns with engineered fluid channels to purify biological products directly from unclarified bioreactor harvest, potentially eliminating conventional clarification steps.
◆ Sectors
◆ Business
Modelhardware
CustomerBiotechnology and pharmaceutical companies involved in biologics, vaccine, cell and gene therapy, and other medicinal-therapeutics manufacturing.
◆ Notable
- Raised a seed round led by M Ventures, with participation from Bridgewest Ventures NZ, Icehouse Ventures, and New Zealand Growth Capital Partners’ Aspire fund.
- Developed technology originating from more than a decade of University of Canterbury research.
- Conducting technology-validation trials with AstraZeneca.
- Received funding from the U.S. Biomedical Advanced Research and Development Authority.
- Planning a Christchurch manufacturing plant and commercial product launch.
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Precision Chroma do?
Christchurch-based biotechnology startup developing a new method of chromatography for faster and simpler purification of biological products.
Where is Precision Chroma based?
Precision Chroma is based in Christchurch, New Zealand, founded in 2022.
How much has Precision Chroma raised?
Precision Chroma has raised $7.3M in tracked funding and is currently at the seed stage.
Who has invested in Precision Chroma?
Investors in Precision Chroma include M Ventures, Bridgewest Ventures NZ, Icehouse Ventures and New Zealand Growth Capital Partners.